I am a biologist with an MSc and PhD in Molecular Biology from Autonoma University in Madrid, Spain. After significant experience in molecular and cellular biology in animal and human viruses, I switched to cancer bioinformatics in 2005. My main expertise includes the transcriptome analysis of tumor samples from genetically engineered mouse models of cancer and human cancer. Major aims include the development of predictors of clinical outcomes and response to therapies based on the molecular features of cancer patients and clinico-pathology variables. I have worked at the Center for Molecular Biology "Severo Ochoa" (CBMSO) in Spain, the Agricultural University of Wageningen in Holland, Cancer Research UK (CRUK) and the Institute of Oncology Research (IOR) in Switzerland. Currently, I am working on i) a molecular basis of initiation, progression and metastasis of squamous head and neck cancer (HNSCC); ii) disease models, including genetically engineered mouse models; and iii) liquid biopsies for the early diagnosis and detection of recurrent/metastatic HNSCC. I am mainly focused on HNSCC in Fanconi anemia patients.
I am a biologist with an MSc and PhD in Molecular Biology from Autonoma University in Madrid, Spain. After significant experience in molecular and cellular biology in animal and human viruses, I switched to cancer bioinformatics in 2005. My main expertise includes the transcriptome analysis of tumor samples from genetically engineered mouse models of cancer and human cancer. Major aims include the development of predictors of clinical outcomes and response to therapies based on the molecular features of cancer patients and clinico-pathology variables. I have worked at the Center for Molecular Biology "Severo Ochoa" (CBMSO) in Spain, the Agricultural University of Wageningen in Holland, Cancer Research UK (CRUK) and the Institute of Oncology Research (IOR) in Switzerland. Currently, I am working on i) a molecular basis of initiation, progression and metastasis of squamous head and neck cancer (HNSCC); ii) disease models, including genetically engineered mouse models; and iii) liquid biopsies for the early diagnosis and detection of recurrent/metastatic HNSCC. I am mainly focused on HNSCC in Fanconi anemia patients.